Parinaud syndrome due to cofirmed neurotuberculosis in a lupus eritematosis systemic patient.

Autor: Tavares-Júnior JWL; Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, CE, Brazil., Teles Júnior JN; Medical coordination of the intensive care unit of Hospital Genesis, Fortaleza, CE, Brazil., Magalhães SC; Universidade de Fortaleza - UNIFOR, Fortaleza, CE, Brazil., Cavalcante TT; Centro Universitário Christus, Fortaleza, CE, Brazil., Coimbra PPA; Uniclinic Diagnóstico por Imagem- UDI Fortaleza, Centro Universitario Chirstus, Fortaleza, CE, Brazil., Luiz RDSS; Ministério da Saúde BR, Fortaleza, CE, Brazil.
Jazyk: angličtina
Zdroj: European journal of ophthalmology [Eur J Ophthalmol] 2023 Jul; Vol. 33 (4), pp. NP138-NP142. Date of Electronic Publication: 2022 Apr 28.
DOI: 10.1177/11206721221098284
Abstrakt: Introduction: This article aims to describe a patient with Parinaud syndrome due to neurotuberculosis confirmed by cerebrospinal fluid analysis.
Case Report: Initially, patient sought medical care, performed a chest x-ray and later a chest CT scan, with a probable diagnosis of miliary tuberculosis. In addition, she presented binocular diplopia worse at right lateral gaze, paresis of vertical gaze, light near-dissociation and convergent retraction nystagmus and presence of mycobacterium tuberculosis on PCR Xpert MTB/RIF. The treatment of miliary tuberculosis was interrupted due to pharmacodermia, but after diagnosis of neurotuberculosis, it was restarted with isoniazid, pyrazinamide and ethambutol with partial visual symptoms improvement.
Discussion: This case demonstrates the importance of pursuing diagnosis through more accurate techniques, especially in a patient with previous treatment pharmacoderma, whose absence of proper diagnosis and treatment would be extremely deleterious.
Databáze: MEDLINE